Focused on ophthalmology, the Japanese drugmaker develops and commercializes prescription pharmaceuticals and medical devices for eye conditions such as glaucoma, dry eye, and retinal disorders. The company generates most of its revenue in Japan while expanding across Asia and Europe, positioning it...
No congressional trades have been disclosed for Santen Pharmaceutical Co., Ltd. (SNPHY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.